Treatment of Hyperthyroidism 99 54, Ben-Porath, M.. Feige, Y., Lubin, E., et al.: Microdosimetry of 1-125 in the thyroid follicle. J. Nucl. Med. 11:300-301, 1970 (Abst.). 55. Snyder, W. S., Ford, M. R., Warner, G. G., et al.: °°S’’ absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. II, Society of Nuclear Medicine, 1975. 56. Gross, J., Ben-Porath, M., Rosin, A., et al.: A comparison of radiobiologic effects of ‘317 and '*51 respectively on the rat thyroid. In: Thyroid Neoplasia, S. Young and D. R. Inman (eds.). London and New York, Academic Press, pp. 291-306, 1968. 57. Greig, W. R., Smith, J. F. B., Orr, J. S., et al.: Comparative survivals of rat thyroid cells in vivo after "J, '*5] and X irradiations. Br. J. Radiol. 43:542-548, 1970. 58. Vickery, A. L., Jr., Williams, E. D.: Comparative biological effects of !°1 and ''I on the rat thyroid. Acta Endocrinol. (Kbh.) 66:201-212, 1971. 59. Lewitus, Z., Rechnic, J.: Electron-microscopic and isotopic evidence for a difference between the radiobiological effects of iodine-131 and iodine-125. In: Radioactive Isotope in Klinik und Forschung, Band II, Gasteiner Internationales Symposion 1974, R. Hofer (ed.). Vienna, Urban & Schwarzenberg, pp. 44-51, 1975. Jongejan. W. J., Van Putten, L. M.: The effects of 'I and '5I on mouse and rat thyroid. Int. J. Radiat. Biol. 22:489-499, 1972. 61. Greig, W. R., Smith, J. F. B., Gillespie, F. C., et al.: Iodine-125 treatment for thyrotoxicosis. Lancet 1:755—-757, 1969. 62. McDougall, I. R., Greig, W. R., Gillespie, F. C.: Radioactive iodine (51) therapy for thyrotoxicosis. N. Engl. J. Med. 285:1099-1104, 1971. 63. Bremner, W. F.. McDougall, I. R., Greig, W. R.: Results of treating 297 thyrotoxic patients with '1, Lancet 2:218-282, 1973. McDougall, I. R., Greig, W. R.: }251 therapy in Graves’s disease. Ann. Intern. Med. 85:720-723, 1976. 65. Lewitus, Z.: lodine-125 treatment for thyrotoxicosis. Lancet 2:1368, 1969. 66. Lewitus, Z., Lubin, E., Rechnic, J., et al.: Treatment of thyrotoxicosis with 51 and 1311 Semin. Nucl. Med. 1:411-421, 1971. 67. Siemsen, J., Wallack, M. S., Martin, R. B., et al.: Early results of '1 therapy of thyrotoxic Graves’ disease. J. Nucl. Med. 15:257-260, 1974. 68. Werner,S. C., Johnson, P. M., Goodwin, P. N., et al.: Long term results with iodine125 treatment for toxic diffuse goiter. Lancet 2:681-685, 1970. 69. Weidinger, P., Johnson, P. M., Werner, S. C.: Five years’ experience with iodine-125 therapy of Graves’s disease. Lancet 2:74-77, 1974. 70. Glanzmann, C., Horst, W.: Ergebnisse der Therapie der Hyperthyreose mit 125- Jod. Nucl. Med. 14:207-218, 1975. 71. Gimlette, T. M. D., Hoschl, R.: Treatment of thyrotoxicosis with iodine-125 in moderately low dosage. Clin. Radiol. 24:263-266, 1973. 72. Malone, J. F., Cullen, M. J.: Two mechanisms for hypothyroidism after '*'I therapy. Lancet 2:73-75, 1976.